Диссертация (1140658), страница 18
Текст из файла (страница 18)
– 2003. – Т.101. – №. 6. – 2132-2135 p.91.Herrmann J. J., Roenigk H.H., Hurria A., Kuzel T.M., Samuelson E.,Rademaker A.W., Rosen S.T. Treatment of mycosis fungoides withphotochemotherapy (PUVA): long-term follow-up //Journal of the AmericanAcademy of Dermatology. – 1995. – Т. 33. – №. 2. – 234-242 p.92.Horwitz S. M. Olsen E. A., Duvic M., Porcu P., Kim, Y. H. Review ofthe treatment of mycosis fungoides and Sézary syndrome: a stage-basedapproach //Journal of the National Comprehensive Cancer Network.
– 2008.– Т. 6. – №. 4. – 436-442 p.93.Izban K. F., Hsi E. D., Alkan S. Immunohistochemical analysis ofmycosis fungoides on paraffin-embedded tissue sections //Modernpathology: an official journal of the United States and Canadian Academy ofPathology, Inc. – 1998. – Т. 11. – №. 10. – 978-982 p.94.Jawed S.I., Myskowski P.L., Horwitz S., Moskowitz A., Querfeld C.Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézarysyndrome): part I. Diagnosis: clinical and histopathologic features and newmolecular and biologic markers //Journal of the American Academy ofDermatology. – 2014.
– Т. 70. – №. 2. – 205. e1-205. e16 p.13895.Johnson V. E., Vonderheid E.C., Hess A.D., Eischen C.M., McGirtL.Y. Genetic markers associated with progression in early mycosisfungoides //Journal of the European Academy of Dermatology andVenereology. – 2014. – Т. 28. – №. 11. – 1431-1435 p.96.Juliusberg F. Idem. – Jadassohn J. Handbuch der Haut-undGeschlechtskrankheiten. 1928. – Vol. 1. – 289-341 p.97.Karipidis K., Benke G., Sim M., Fritschi L., Yost M., Armstrong B.,Kricker A. Occupational exposure to power frequency magnetic fields andrisk of non-Hodgkin lymphoma //Occupational and environmental medicine.– 2007. – Т. 64. – №. 1.
– 25-29 p.98.Keehn C. A., Belongie I.P., Shistik G., Fenske N.A., Glass L.F. Thediagnosis, staging, and treatment options for mycosis fungoides //CancerControl. – 2007. – Т. 14. – №. 2. – 102-111 p.99.Kelly J. L., Drake M. T., Fredericksen Z. S., Asmann Y. W., LiebowM., Shanafelt T. D., Wang A. H. Early life sun exposure, vitamin D-relatedgene variants, and risk of non-Hodgkin lymphoma //Cancer Causes &Control. – 2012. – Т. 23.
– №. 7. – 1017-1029 p.100. Kikuchi A., Naka W., Harada T., Sakuraoka K., Harada R., NishikawaT. Parapsoriasis en plaques: its potential for progression to malignantlymphoma //Journal of the American Academy of Dermatology. – 1993. – Т.29.
– №. 3. – 419-422 p.101. Kim E. J., Hess S., Richardson S. K., Newton S., Showe L. C., BenoitB. M., Rook A. H. Immunopathogenesis and therapy of cutaneous T celllymphoma //The Journal of clinical investigation. – 2005. – Т. 115. – №. 4.– 798-812 p.102. Kim Y. H., Liu H. L., Mraz-Gernhard S., Varghese A., Hoppe R. T.Long-term outcome of 525 patients with mycosis fungoides and Sezarysyndrome: clinical prognostic factors and risk for disease progression//Archives of dermatology.
– 2003. – Т. 139. – №. 7. – 857-866 p.139103. Kim E. J., Hess S., Richardson S. K., Newton S., Showe L. C., BenoitB. M., Rook A. H. Immunopathogenesis and therapy of cutaneous T celllymphoma //The Journal of clinical investigation. – 2005. – Т. 115. – №. 4.– 798-812 p.104. King-Ismael D., Ackerman A. B. Guttate parapsoriasis/digitatedermatosis (small plaque parapsoriasis) is mycosis fungoides //TheAmerican journal of dermatopathology. – 1992.
– Т. 14. – №. 6. – 518-30 p.;discussion 531-5.105. Kopp K.L., Ralfkiaer U., Gjerdrum L.M., Helvad R., Pedersen I.H.,Litman T., Jønson L., Hagedorn P.H., Krejsgaard T., Gniadecki R. STAT5mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma//Cell cycle. – 2013. – Т. 12. – №. 12. – 1939-1947 p.106. Krejsgaard T., Odum N., Geisler C., Wasik M.A., Woetmann A.Regulatory T cells and immunodeficiency in mycosis fungoides and Sezarysyndrome //Leukemia. – 2012.
– Т. 26. – №. 3. – 424-432 p.107. Krejsgaard T., Ralfkiaer U., Clasen-Linde E., Eriksen K. W., Kopp K.L., Bonefeld C. M., Woetmann A. Malignant cutaneous T-cell lymphomacells express IL-17 utilizing the Jak3/Stat3 signaling pathway //Journal ofInvestigative Dermatology. – 2011.
– Т. 131. – №. 6. – 1331-1338 p.108. Kreuter A., Bischoff S., Skrygan M., Wieland U., Brockmeyer N. H.,Stücker M., Gambichler T. High association of human herpesvirus 8 inlarge-plaqueparapsoriasisandmycosisfungoides//Archivesofdermatology. – 2008. – Т. 144. – №. 8. – 1011-1016 p.109. Kuzel T. M., Roenigk Jr H. H., Samuelson E., Herrmann J. J., HurriaA., Rademaker A. W., Rosen S. T. Effectiveness of interferon alfa-2acombined with phototherapy for mycosis fungoides and the Sézarysyndrome //Journal of clinical oncology. – 1995. – Т. 13.
– №. 1. – 257-263p.140110. Lambert W. C., Everett M. A. The nosology of parapsoriasis //Journalof the American Academy of Dermatology. – 1981. – Т. 5. – №. 4. – 373395 p.111. Lasek W., Zagożdżon R., Jakobisiak M. Interleukin 12: still apromising candidate for tumor immunotherapy? //Cancer Immunology,Immunotherapy. – 2014. – Т. 63.
– №. 5. – 419-435 p.112. Lazar, A. P. Parapsoriasis and mycosis fungoides: the NorthwesternUniversity experience , 1970 to 1985 / A.P. Lazar, W.A. Caro, H.H.Roenigk et al. // J Am Acad Dermatol. ― 1989 Vol. 5 ― P.919-923.113. Lazar A. P., Caro W. A., Roenigk Jr.
H. H., Pinski K. S. Parapsoriasisand mycosis fungoides: the Northwestern University experience, 1970 to1985 //Journal of the American Academy of Dermatology. – 1989. – Т. 21. –№. 5. – 919-923 p.114. Litvinov I. V., Cordeiro B., Fredholm S., Ødum N., Zargham H.,Huang Y. Analysis of STAT4 expression in cutaneous T-cell lymphoma(CTCL) patients and patient-derived cell lines //Cell cycle. – 2014. – Т. 13.– №. 18. – 2975-2982 p.115.
Litvinov I. V., Netchiporouk E., Cordeiro B., Zargham H., Pehr K.,Gilbert M., Zhou Y., Moreau L., Woetmann A., Ødum N., Kupper T.S.Ectopic expression of embryonic stem cell and other developmental genes incutaneous T-cell lymphoma //Oncoimmunology. – 2014. – Т. 3. – №. 11.
–e970025 p.116. Liszewski W., Naym D.G., Biskup E., Gniadecki R. Psoralen withultraviolet A‐induced apoptosis of cutaneous lymphoma cell lines isaugmented by type I interferons via the JAK1–STAT1 pathway//Photodermatology, photoimmunology & photomedicine. – 2017. – Т. 33. –№. 3.
– 164-171 p.117. Lynch S. M., Mahajan R., Freeman L. E. B., Hoppin J. A., AlavanjaM. C. Cancer incidence among pesticide applicators exposed to butylate in141the Agricultural Health Study (AHS) //Environmental research. – 2009. – Т.109. – №. 7. – 860-868 p.118. Mao X., Lillington D., Scarisbrick J.J., Mitchell T., Czepulkowski B.,Russell-Jones R. Molecular cytogenetic analysis of cutaneous T‐celllymphomas: identification of common genetic alterations in Sézarysyndrome and mycosis fungoides //British Journal of Dermatology. – 2002.– Т.
147. – №. 3. – 464-475 p.119. Mao X., Orchard G., Vonderheid E.C., No well P.C., Bagot M.,Bensussan A. Heterogeneous abnormalities of CCND1 and RB1 in primarycutaneous T-Cell lymphomas suggesting impaired cell cycle control indisease pathogenesis //Journal of Investigative Dermatology. – 2006. – Т.126.
– №. 6. – 1388-1395 p.120. Mao X., Orchard G., Mitchell T. J., Oyama N., Russell‐Jones R.,Vermeer M. H., Whittaker S. J. A genomic and expression study of AP‐1 inprimary cutaneous T‐cell lymphoma: evidence for dysregulated expressionof JUNB and JUND in MF and SS //Journal of cutaneous pathology. – 2008.– Т. 35. – №. 10. – 899-910 p.121. McKee P. H., Calonje E., Lazar A., Brenn T. McKee's Pathology ofthe Skin: With Clinical Correlations. – Elsevier Saunders, 2012. - 1311-1420p.122.
McPherson R. A., Pincus M. R. Henry's Clinical Diagnosis andManagement by Laboratory Methods E-Book. – Elsevier Health Sciences,2017. - 1271–1281 p.123. Merhi M., Raynal H., Cahuzac E., Vinson F., Cravedi J. P., GametPayrastre L. Occupational exposure to pesticides and risk of hematopoieticcancers: meta-analysis of case–control studies //Cancer Causes & Control. –2007. – Т.
18. – №. 10. – 1209-1226 p.124. Mignatti P., Rifkin D. B. Plasminogen activators and matrixmetalloproteinases in angiogenesis //Enzyme and Protein. – 1996. – Т. 49. –№13. – 117-137 p.142125. Morales-Suárez-Varela M. M., Olsen J., Johansen P., Kaerlev L.,Guénel P., Arveux P., Llopis A. Occupational exposures and MycosisFungoides. A European multicentre case–control study (Europe) //CancerCauses & Control. – 2005.
– Т. 16. – №. 10. – 1253-1259 p.126. Mueller K. K., Yeager J. K. Clinical considerations in digitatedermatosis // International journal of dermatology. – 1997. – Т. 36. – №. 10.– 767-767 p.127. Nag F., Ghosh A., Biswas P., Chatterjee G., Biswas S. Ichthyosiformlarge plaque parapsoriasis: Report of a rare entity // Indian journal ofdermatology. – 2013. – Т. 58. – №. 5. – 385 p.128. Navas I. C., Ortiz-Romero P. L., Villuendas R., Martínez P., GarcíaC., Gómez E., Piris M. A. p16INK4a gene alterations are frequent in lesionsof mycosis fungoides //The American journal of pathology. – 2000.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
